Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2026-02-20 @ 1:43 PM
Study NCT ID:
NCT03319459
Status:
COMPLETED
Last Update Posted:
2021-11-22
First Post:
2017-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-18
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-15
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-19
First Submit QC Date:
None
Study First Post Date:
2017-10-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-18
Last Update Post Date:
2021-11-22
Last Update Post Date Type:
ACTUAL